Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tg Therapeuticscmn (NQ: TGTX )

5.440 +0.050 (+0.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 23, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,532,711
Open 5.470
Bid (Size) 5.300 (1)
Ask (Size) 5.500 (1)
Prev. Close 5.390
Today's Range 5.260 - 5.580
52wk Range 4.810 - 41.00
Shares Outstanding 144,435,369
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Peering Into TG Therapeutics's Recent Short Interest
TG Therapeutics's (NASDAQ:TGTX) short percent of float has fallen 8.05% since its last report. The company recently reported that it has 19.37 million shares sold short, which is... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga

Performance

YTD
-73.40%
-73.40%
1 Month
-23.70%
-23.70%
3 Month
-45.98%
-45.98%
6 Month
-77.25%
-77.25%
1 Year
-83.87%
-83.87%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022
Via Benzinga
What 4 Analyst Ratings Have To Say About TG Therapeutics
Via Benzinga
Expert Ratings for TG Therapeutics
Via Benzinga
Despite Price Cut, HC Wainwright Keeps Buy Rating On TG Therapeutics - Read Why
Via Benzinga
TG Therapeutics Retracts FDA Request For Ublituximab / Ukoniq Combo In Blood Cancers
Via Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Mid-Afternoon Market Update: Crude Oil Rises Over 1%; Nektar Therapeutics Shares Slide
Via Benzinga
68 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Mid-Day Market Update: U.S. Stocks Turn Lower; Bank of America Earnings Top Views
Via Benzinga
34 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; Dow Gains 100 Points
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why TG Therapeutics Stock Is Plunging Today
Via Benzinga
10 Biggest Price Target Changes For Monday
Via Benzinga
21 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
Via Benzinga
TG Therapeutics, Inc. (NASDAQ:TGTX) Investor Alert: Investigation over Potential Wrongdoing
Via SBWire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.